On July 11, 2023, Centrexion Therapeutics Corp. closed the transaction. The company received $10,280,238 from 124 investors in the transaction.
Centrexion Therapeutics Corporation
Equities
CNTX
US15643W1009
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+38.36% | 52.73B | |
+39.10% | 39B | |
-8.63% | 38.52B | |
+25.46% | 30.38B | |
-11.17% | 26.39B | |
+11.44% | 26.08B | |
+45.09% | 14.15B | |
+32.93% | 12.6B | |
-5.30% | 11.51B |